-
Perspectives on the Cost Effectiveness Threshold in Health Care for the United States
Webinar 5 -
ICER's Use of the QALY and the evLYG
How can we determine a fair price based on how well a drug works?Comments
No comments yet. Create an account and log in to post a comment.
-
CTAF Public Meeting on Modulator Treatments for Cystic Fibrosis: Evidence Presentation
ICER meeting on modulator treatments for Cystic Fibrosis.Comments
No comments yet. Create an account and log in to post a comment.
-
Pricing in a Pandemic ICER Colloquium Series: Session 3, Monetary Prizes, Compulsory Licensing, AMCs
The third colloquium will cover monetary prizes, compulsory licensing, and advanced market commitments.Comments
No comments yet. Create an account and log in to post a comment.
-
Pricing in a Pandemic ICER Colloquium Series: Session 2, Cost-Effectiveness and Value-Based Pricing
This second colloquium covers value-based pricing through which cost-effectiveness analysis is used set a ceiling price based on the degree of added benefit for patients and society.Comments
No comments yet. Create an account and log in to post a comment.
-
Pricing in a Pandemic ICER Colloquium Series: Session One, Cost-Recovery Pricing
The first colloquium covered cost-recovery pricing in which prices are set at a level needed to cover all the costs borne by the manufacturer in making the treatment.Comments
No comments yet. Create an account and log in to post a comment.
-
ICER's Updated Value Assessment Framework
Overview of ICER's updated value assessment framework. -
Trustworthy and Independent
Where ICER steps in.Comments
No comments yet. Create an account and log in to post a comment.
Comments